Insiders · ERNA

ERNA insider transactions

Ernexa Therapeutics Inc. (ERNA) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.

ERNA insiders

Everyone who has filed a Form 4 or 5 at Ernexa Therapeutics Inc., latest first. Follow anyone to get their next filing.

• James Arthur BristolDirector
• Peter CicalaDirector
• David PolinskyDirector
• William A. WexlerDirector
• Elena RatnerDirector
• Sanjeev LutherPresident and CEO, Director
• Charles CheringtonDirector, 10% owner+$5.47M
• Sandra M GurrolaSr. VP of Finance
• Dorothy J ClarkeGeneral Counsel, Director
• Freebird Partners LP10% owner
• Brant BinderDirector
• Richard W WagnerDirector
• Matthew AngelOfficer, Director
• Nicholas Jason SingerDirector+$929K
• John D Halpern10% owner+$1.1M
• Roger SidhuOfficer
• Gregory FioreDirector
• Kevin DAmourOfficer
• Andrew C. JacksonOfficer
• Jay SialOfficer
• Howard J. FederoffOfficer, Director
• Heather B RedmanDirector
• Erin S. EnrightDirector
• Luba GreenwoodDirector
• Erich MohrDirector
• Dennis LangerDirector
• George P Denny III10% owner+$40.45-$1.2M
• Allen WolffOfficer, Director

Recent Form 3, 4, and 5 filings for ERNA

• 44d
  SEC Form 3 filed by new insider Spiegel Robert J.

  3 - Ernexa Therapeutics Inc. (0000748592) (Issuer)
• 65d
  SEC Form 4 filed by Director Bristol James Arthur

  4 - Ernexa Therapeutics Inc. (0000748592) (Issuer)
• 65d
  SEC Form 4 filed by Director Cicala Peter

  4 - Ernexa Therapeutics Inc. (0000748592) (Issuer)
• 65d
  SEC Form 4 filed by Director Wexler William A.

  4 - Ernexa Therapeutics Inc. (0000748592) (Issuer)
• 65d
  SEC Form 4 filed by Director Polinsky David

  4 - Ernexa Therapeutics Inc. (0000748592) (Issuer)
• 65d
  SEC Form 4 filed by Director Ratner Elena

  4 - Ernexa Therapeutics Inc. (0000748592) (Issuer)
• 65d
  SEC Form 4 filed by President and CEO Luther Sanjeev

  4 - Ernexa Therapeutics Inc. (0000748592) (Issuer)
• 70d
  New insider Polinsky David claimed ownership of 8,000 shares (SEC Form 3)

  3 - Ernexa Therapeutics Inc. (0000748592) (Issuer)
• 261d
  Large owner Cherington Charles bought $2,000,000 worth of shares (4,000,000 units at $0.50), increasing direct ownership by 144% to 6,779,440 units (SEC Form 4)

  4 - Ernexa Therapeutics Inc. (0000748592) (Issuer)
• 486d
  Sr. VP of Finance Gurrola Sandra M converted options into 30 shares, increasing direct ownership by 38% to 110 units (SEC Form 4)

  4 - Ernexa Therapeutics Inc. (0000748592) (Issuer)
• 512d
  Large owner Cherington Charles bought $2,221,826 worth of shares (21,241,163 units at $0.10), increasing direct ownership by 104% to 41,659,743 units (SEC Form 4)

  4 - Ernexa Therapeutics Inc. (0000748592) (Issuer)
• 548d
  Amendment: Large owner Cherington Charles bought 13,252,112 shares, increasing direct ownership by 2,381% to 13,808,577 units (SEC Form 4)

  4/A - Ernexa Therapeutics Inc. (0000748592) (Issuer)
• 581d
  Large owner Cherington Charles bought $394,174 worth of shares (3,768,397 units at $0.10), increasing direct ownership by 23% to 20,401,602 units (SEC Form 4)

  4 - Eterna Therapeutics Inc. (0000748592) (Issuer)
• 633d
  SEC Form 4 filed by Director Wexler William A.

  4 - Eterna Therapeutics Inc. (0000748592) (Issuer)
• 633d
  SEC Form 4 filed by Sr. VP of Finance Gurrola Sandra M

  4 - Eterna Therapeutics Inc. (0000748592) (Issuer)
• 633d
  SEC Form 4 filed by Director Bristol James Arthur

  4 - Eterna Therapeutics Inc. (0000748592) (Issuer)
• 633d
  SEC Form 4 filed by Director Cicala Peter

  4 - Eterna Therapeutics Inc. (0000748592) (Issuer)
• 633d
  SEC Form 4 filed by President & CEO Luther Sanjeev

  4 - Eterna Therapeutics Inc. (0000748592) (Issuer)
• 660d
  SEC Form 4 filed by Director Ratner Elena

  4 - Eterna Therapeutics Inc. (0000748592) (Issuer)
• 660d
  SEC Form 3 filed by new insider Ratner Elena

  3 - Eterna Therapeutics Inc. (0000748592) (Issuer)
• 731d
  Large owner Cherington Charles bought 13,252,112 shares and converted options into 2,819,546 shares, increasing direct ownership by 2,888% to 16,628,123 units (SEC Form 4)

  4 - Eterna Therapeutics Inc. (0000748592) (Issuer)
• 863d
  Sr. VP of Finance Gurrola Sandra M converted options into 437 shares and covered exercise/tax liability with 180 shares, increasing direct ownership by 28% to 1,185 units (SEC Form 4)

  4 - Eterna Therapeutics Inc. (0000748592) (Issuer)
• 920d
  SEC Form 4 filed by Cicala Peter

  4 - Eterna Therapeutics Inc. (0000748592) (Issuer)
• 920d
  SEC Form 4 filed by Bristol James Arthur

  4 - Eterna Therapeutics Inc. (0000748592) (Issuer)
• 920d
  SEC Form 4 filed by Gurrola Sandra M

  4 - Eterna Therapeutics Inc. (0000748592) (Issuer)